These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 21362374

  • 1. Pharmacokinetic study of single and multiple oral dose administration of antofloxacin hydrochloride in healthy male volunteers.
    Lü Y, Kang ZS, Zhu Y, Zhang M, Liu Y, Zhang M, Li TY, Xiao YH.
    Chin Med J (Engl); 2011 Jan; 124(2):242-5. PubMed ID: 21362374
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of antofloxacin hydrochloride, a new fluoroquinolone antibiotic, after single oral dose administration in Chinese healthy male volunteers.
    Xiao Y, Lu Y, Kang Z, Zhang M, Liu Y, Zhang M, Li T.
    Biopharm Drug Dispos; 2008 Apr; 29(3):167-72. PubMed ID: 18240275
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of antofloxacin hydrochloride in healthy male subjects after multiple intravenous dose administration.
    Wang J, Xiao Y, Lu Y, Kang Z, Zhang M, Liu Y, Liang J, Zhang M, Li T.
    Xenobiotica; 2011 Jul; 41(7):561-6. PubMed ID: 21446836
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Tolerability and pharmacokinetics of antofloxacin hydrochloride after multiple oral dose administration in healthy Chinese male volunteers.
    Xiao Y, Lu Y, Kang Z, Hou F, Wang S, Li T, Liu Y, Xia Y.
    Int J Clin Pharmacol Ther; 2008 Apr; 46(4):172-9. PubMed ID: 18397690
    [Abstract] [Full Text] [Related]

  • 6. Bioavailability of two oral formulations of a single dose of levofloxacin 500 mg: an open-label, randomized, two-period crossover comparison in healthy Mexican volunteers.
    Galan-Herrera JF, Poo JL, Rosales-Sanchez O, Fuentes-Fuentes E, Cariño L, Burke-Fraga V, Namur S, Parra MG.
    Clin Ther; 2009 Aug; 31(8):1796-803. PubMed ID: 19808138
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of ofloxacin in broiler chicken.
    Kalaiselvi L, Sriranjani D, Ramesh S, Sriram P, Mathuram LN.
    J Vet Pharmacol Ther; 2006 Jun; 29(3):185-9. PubMed ID: 16669862
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics of antofloxacin hydrochloride, a novel fluoroquinolone, after single-dose intravenous administration in healthy Chinese male volunteers.
    Wang J, Xiao Y, Lu Y, Kang Z, Zhang M, Liu Y, Liang J, Zhang M, Li T.
    Xenobiotica; 2010 May; 40(5):344-9. PubMed ID: 20230254
    [Abstract] [Full Text] [Related]

  • 11. Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose.
    Wagenlehner FM, Kinzig-Schippers M, Tischmeyer U, Wagenlehner C, Sörgel F, Dalhoff A, Naber KG.
    Int J Antimicrob Agents; 2006 Jan; 27(1):7-14. PubMed ID: 16343856
    [Abstract] [Full Text] [Related]

  • 12. The pharmacokinetics of antofloxacin in renally impaired rats.
    Pang XY, Liu L, Zhang DM, Wang GJ, Xie L, Liu XD.
    J Pharm Pharmacol; 2008 May; 60(5):667-70. PubMed ID: 18416945
    [Abstract] [Full Text] [Related]

  • 13. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for the determination of levofloxacin in human plasma.
    Ji HY, Jeong DW, Kim YH, Kim HH, Sohn DR, Lee HS.
    J Pharm Biomed Anal; 2006 May 03; 41(2):622-7. PubMed ID: 16423485
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics and safety of single rising doses of ofloxacin in healthy volunteers.
    Marchbanks CR, Dudley MN, Flor S, Beals B.
    Pharmacotherapy; 1992 May 03; 12(1):45-9. PubMed ID: 1549538
    [Abstract] [Full Text] [Related]

  • 16. Urinary bactericidal activity of single doses (250, 500, 750 and 1000 mg) of levofloxacin against fluoroquinolone-resistant strains of Escherichia coli.
    Stein GE, Schooley SL, Nicolau DP.
    Int J Antimicrob Agents; 2008 Oct 03; 32(4):320-5. PubMed ID: 18715762
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetics/pharmacodynamics of antofloxacin hydrochloride in a neutropenic murine thigh model of Staphylococcus aureus infection.
    Xiao XM, Xiao YH.
    Acta Pharmacol Sin; 2008 Oct 03; 29(10):1253-60. PubMed ID: 18817632
    [Abstract] [Full Text] [Related]

  • 18. Tear concentration and safety of levofloxacin ophthalmic solution 1.5% compared with ofloxacin ophthalmic solution 0.3% after topical administration in healthy adult volunteers.
    Walters T, Rinehart M, Krebs W, Holdbrook M.
    Cornea; 2010 Mar 03; 29(3):263-8. PubMed ID: 20098307
    [Abstract] [Full Text] [Related]

  • 19. A phase II study of antofloxacin hydrochloride, a novel fluoroquinolone, for the treatment of acute bacterial infections.
    Wang J, Xiao Y, Huang W, Xu N, Bai C, Xiu Q, Mei C, Zheng Q.
    Chemotherapy; 2010 Mar 03; 56(5):378-85. PubMed ID: 20938175
    [Abstract] [Full Text] [Related]

  • 20. Mechanism-based inhibition of CYP1A2 by antofloxacin, an 8-NH2 derivative of levofloxacin in rats.
    Zhu Q, Liao J, Xie L, Wang GJ, Liu XD.
    Xenobiotica; 2009 Apr 03; 39(4):293-301. PubMed ID: 19350452
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.